Role of the ubiquitin-like modifier FAT10 in protein degradation and ...

More documents

Recommendations

Info

References S. S. Hook, A. Orian, S. M. Cowley, and R. N. Eisenman. Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc Natl Acad Sci U S A, 99(21):13425–13430, Oct 2002. T. Hoppe. Multiubiquitylation by E4 enzymes: ’one size’ doesn’t fit all. Trends Biochem Sci, 30(4): 183–187, Apr 2005. P. Hornbeck. Current Protocols in Immunology: Unit 2.1 Enzyme-Linked Immunosorbent Assays. John Wiley & Sons, 1992. M. A. Hoyt, J. Zich, J. Takeuchi, M. Zhang, C. Govaerts, and P. Coffino. Glycine-alanine repeats impair proper substrate unfolding by the proteasome. EMBO J, 25(8):1720–1729, Apr 2006. C. Hubbert, A. Guardiola, R. Shao, Y. Kawaguchi, A. Ito, A. Nixon, M. Yoshida, X. F. Wang, and T. P. Yao. HDAC6 is a microtubule-associated deacetylase. Nature., 417(6887):455–8., 2002. J. H. Hurley, S. Lee, and G. Prag. Ubiquitin-binding domains. Biochem J, 399(3):361–372, Nov 2006. D. R. Hurst, A. Mehta, B. P. Moore, P. A. Phadke, W. J. Meehan, M. A. Accavitti, L. A. Shevde, J. E. Hopper, Y. Xie, D. R. Welch, and R. S. Samant. Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. Biochem Biophys Res Commun, 348(4):1429–1435, Oct 2006. K. Husnjak, S. Elsasser, N. Zhang, X. Chen, L. Randles, Y. Shi, K. Hofmann, K. J. Walters, D. Finley, and I. Dikic. Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature, 453(7194): 481–488, May 2008. A. Iwata, B. E. Riley, J. A. Johnston, and R. R. Kopito. HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem, 280(48):40282–40292, Dec 2005. D. M. Janse, B. Crosas, D. Finley, and G. M. Church. Localization to the proteasome is sufficient for degradation. J Biol Chem, 279(20):21415–21420, May 2004. S. Jentsch and G. Pyrowolakis. Ubiquitin and its kin: how close are the family ties? Trends Cell Biol, 10(8):335–342, Aug 2000. S. Jentsch, W. Seufert, T. Sommer, and H. A. Reins. Ubiquitin-conjugating enzymes: novel regulators of eukaryotic cells. Trends Biochem Sci, 15(5):195–198, May 1990. S. Jentsch, W. Seufert, and H. P. Hauser. Genetic analysis of the ubiquitin system. Biochim Biophys Acta, 1089(2):127–139, Jun 1991. V. Jesenberger and S. Jentsch. Deadly encounter: ubiquitin meets apoptosis. Nat Rev Mol Cell Biol, 3(2):112–121, Feb 2002. J. Jiang, C. A. Ballinger, Y. Wu, Q. Dai, D. M. Cyr, J. Höhfeld, and C. Patterson. CHIP is a Ubox-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J Biol Chem, 276(46):42938–42944, Nov 2001. J. Jin, X. Li, S. P. Gygi, and J. W. Harper. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature, 447(7148):1135–1138, Jun 2007. C. A. Joazeiro and A. M. Weissman. RING finger proteins: mediators of ubiquitin ligase activity. Cell, 102(5):549–552, Sep 2000. E. S. Johnson. Protein modification by SUMO. Annu Rev Biochem, 73:355–382, 2004. E. S. Johnson, B. Bartel, W. Seufert, and A. Varshavsky. Ubiquitin as a degradation signal. EMBO J, 11(2):497–505, Feb 1992. E. S. Johnson, P. C. Ma, I. M. Ota, and A. Varshavsky. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J Biol Chem, 270(29):17442–17456, Jul 1995. J. A. Johnston, C. L. Ward, and R. R. Kopito. Aggresomes: a cellular response to misfolded proteins. J Cell Biol, 143(7):1883–1898, Dec 1998. J. A. Johnston, M. J. Dalton, M. E. Gurney, and R. R. Kopito. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A, 97(23):12571–12576, Nov 2000. 131
References J. A. Johnston, M. E. Illing, and R. R. Kopito. Cytoplasmic dynein/dynactin mediates the assembly of aggresomes. Cell Motil Cytoskeleton, 53(1):26–38, Sep 2002. C. Kahana, G. Asher, and Y. Shaul. Mechanisms of protein degradation: an odyssey with ODC. Cell Cycle, 4(11):1461–1464, Nov 2005. B. Kalveram, G. Schmidtke, and M. Groettrup. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition. J. Cell Sci., in press, 2008. A. T. Kamath, J. Pooley, M. A. O’Keeffe, D. Vremec, Y. Zhan, A. M. Lew, A. D’Amico, L. Wu, D. F. Tough, and K. Shortman. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol, 165(12):6762–6770, Dec 2000. T. Kamitani, K. Kito, T. Fukuda-Kamitani, and E. T. Yeh. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem, 276(49):46655–46660, Dec 2001. K. Kanaya, M. M. Sohocki, and T. Kamitani. Abolished interaction of NUB1 with mutant AIPL1 involved in Leber congenital amaurosis. Biochem Biophys Res Commun, 317(3):768–773, May 2004. Y. Kawaguchi, J. J. Kovacs, A. McLaurin, J. M. Vance, A. Ito, and T. P. Yao. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell., 115(6):727–38., 2003. O. Kerscher, R. Felberbaum, and M. Hochstrasser. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol, 22:159–180, 2006. S. Khan, A. Zimmermann, M. Basler, M. Groettrup, and H. Hengel. A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J Virol, 78(4):1831–1842, Feb 2004. K. I. Kim, N. V. Giannakopoulos, H. W. Virgin, and D. E. Zhang. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol Cell Biol., 24(21):9592–600., 2004. K. I. Kim, O. A. Malakhova, K. Hoebe, M. Yan, B. Beutler, and D.-E. Zhang. Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by upregulating type I IFN signaling. J Immunol, 175(2):847–854, Jul 2005. K. Kito, E. T. Yeh, and T. Kamitani. NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J Biol Chem, 276(23):20603–20609, Jun 2001. M. F. Kleijnen, A. H. Shih, P. Zhou, S. Kumar, R. E. Soccio, N. L. Kedersha, G. Gill, and P. M. Howley. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol Cell, 6(2):409–419, Aug 2000. P.-M. Kloetzel. The proteasome and MHC class I antigen processing. Biochim Biophys Acta, 1695 (1-3):225–233, Nov 2004. P. M. Kloetzel and F. Ossendorp. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol, 16(1):76–81, Feb 2004. E. Knight and B. Cordova. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J Immunol, 146(7):2280–2284, Apr 1991. D. M. Koepp, J. W. Harper, and S. J. Elledge. How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell, 97(4):431–434, May 1999. R. R. Kopito. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol., 10(12): 524–30., 2000. J. J. Kovacs, P. J. M. Murphy, S. Gaillard, X. Zhao, J.-T. Wu, C. V. Nicchitta, M. Yoshida, D. O. Toft, W. B. Pratt, and T.-P. Yao. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell, 18(5):601–607, May 2005. P. H. Krammer, R. Arnold, and I. N. Lavrik. Life and death in peripheral T cells. Nat Rev Immunol, 7(7):532–542, Jul 2007. D. Krappmann and C. Scheidereit. A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways. EMBO Rep, 6(4):321–326, Apr 2005. 132
Page 1 and 2:
Role of the ubiquitin-like modifier
Page 3 and 4:
Acknowledgements . . . . . . . . .
Page 5 and 6:
Summary / Zusammenfassung English F
Page 7 and 8:
Summary In conclusion, these result
Page 9 and 10:
Summary nicht von der katalytischen
Page 11 and 12:
The Ubiquitin-Proteasome-System The
Page 13 and 14:
Introduction Figure 1: The 26S prot
Page 15 and 16:
Introduction are the major source o
Page 17 and 18:
Introduction majority of ubiquitin-
Page 19 and 20:
Introduction example contained in t
Page 21 and 22:
Introduction two modifiers apart fr
Page 23 and 24:
Introduction Figure 4: Comparison o
Page 25 and 26:
Introduction dependent apoptosis in
Page 27 and 28:
Introduction Interestingly, a recen
Page 29 and 30:
The Autophagy-Lysosome System Intro
Page 31 and 32:
Introduction Figure 5: Molecular ma
Page 33 and 34:
Introduction The transport of misfo
Page 35 and 36:
Introduction where the proteasome i
Page 37 and 38:
Chapter 1 The UBA domains of NUB1L
Page 39 and 40:
Introduction Chapter 1 Ubiquitin, a
Page 41 and 42:
Chapter 1 no correlation between th
Page 43 and 44:
Chapter 1 covered proteins were sep
Page 45 and 46:
Chapter 1 Figure 8: Accelerated deg
Page 47 and 48:
Chapter 1 Treatment with IFN-γ and
Page 49 and 50:
Chapter 1 ing SUMO-1-GFP or the C-t
Page 51 and 52:
Chapter 1 Figure 12: Accelerated de
Page 53 and 54:
Chapter 1 Figure 13: Co-immunopreci
Page 55 and 56:
Chapter 1 domains of NUB1L is requi
Page 57 and 58:
Chapter 1 Rad23 (Verma et al., 2004
Page 59 and 60:
Chapter 1 FAT10-GFP expressing vect
Page 61 and 62:
Chapter 2 Degradation of FAT10 by t
Page 63 and 64:
Introduction Chapter 2 The proteaso
Page 65 and 66:
Chapter 2 From our previous data it
Page 67 and 68:
Chapter 2 Figure 14: Purified compo
Page 69 and 70:
Chapter 2 evaluation of the NUB1L b
Page 71 and 72:
Chapter 2 teins which contain intri
Page 73 and 74:
Chapter 2 Combined with our studies
Page 75 and 76:
Chapter 2 Recombinant expression of
Page 77 and 78:
Chapter 2 et al., 2003), both at a
Page 79 and 80:
Abstract Chapter 3 During misfolded
Page 81 and 82: Chapter 3 tion between the UPS and
Page 83 and 84: Chapter 3 Figure 18: HDAC6 interact
Page 85 and 86: Chapter 3 Figure 19: Both the BUZ d
Page 87 and 88: Chapter 3 of HDAC6 was required for
Page 89 and 90: Chapter 3 precipitates with HDAC6 (
Page 91 and 92: 90 Chapter 3
Page 93 and 94: Chapter 3 Figure 23: The model conj
Page 95 and 96: Chapter 3 HDAC6 is required for the
Page 97 and 98: Chapter 3 Figure 26: Both ubiquitin
Page 99 and 100: Chapter 3 also revealed endogenous,
Page 101 and 102: Chapter 3 and/or its conjugates is
Page 103 and 104: Chapter 3 (Hipp et al., 2005), pEGF
Page 105 and 106: Chapter 4 FAT10-deficient mice disp
Page 107 and 108: Chapter 4 Once the infection is cle
Page 109 and 110: Chapter 4 As both wild-type as well
Page 111 and 112: Chapter 4 Peptides. The synthetic p
Page 113 and 114: Introduction Chapter 5 Antibodies a
Page 115 and 116: Chapter 5 binant human and mouse GS
Page 117 and 118: Chapter 5 Figure 34: The antibodies
Page 119 and 120: Chapter 5 Figure 36: The antibody s
Page 121 and 122: Discussion 30 years ago, ubiquitin
Page 123 and 124: Discussion monomeric ubiquitin as w
Page 125 and 126: Discussion Alternatively, FAT10 cou
Page 127 and 128: References D. T. Akey, X. Zhu, M. D
Page 129 and 130: References Y.-H. Chiu, Q. Sun, and
Page 131: References S. Gunawardena, L.-S. He
Page 135 and 136: References F. Lévy, N. Johnsson, T
Page 137 and 138: References J.-H. Park, H.-S. Jong,
Page 139 and 140: References P. Schreiner, X. Chen, K
Page 141 and 142: References S. Vijay-Kumar, C. E. Bu
Page 143 and 144: Abbreviations aa amino acid AAA ATP
Page 145 and 146: Amino Acids Alanine Ala A Arginine
show all

Role of the ubiquitin-like modifier FAT10 in protein degradation and ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?